Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer
Status:
Terminated
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine efficacy and safety of paclitaxel, bevacizumab and
enzastaurin versus paclitaxel, bevacizumab, and placebo in participants who are diagnosed
with locally recurrent or metastatic breast cancer.